Physician

Tarvinder Singh Matharu, M.D.

According to 2025 Medicare claims, Tarvinder Matharu, M.D. (NPI: 1912985615) practices internal medicine in the Jackson, MI market, with the plurality of this provider's patient population coming from Jackson, MI. This provider's primary affiliated billing organization is KIDNEY AND HYPERTENSION SPECIALISTS PLLC (NPI: 1174649354; TIN: 201525716) and primary practice location at 49201-1753. Matharu is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Matharu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 341 traditional Medicare patients, billed 1,608 HCPCS/CPT codes, and received $196,368 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,515 prescription claims across 313 beneficiaries totaling $307,595 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2017 DME data shows 28 claims. Open Payments data shows 3 records totaling $50. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $90,133 and ending at $307,595. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	24	91	$8,558
2017	351	1,681	$181,500
2018	406	1,903	$177,536
2019	433	1,720	$164,126
2020	404	1,985	$226,314
2021	442	2,017	$274,162
2022	379	1,638	$220,145
2023	362	1,589	$205,539
2024	341	1,608	$196,368

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	76	304	$90,133
2016	56	320	$117,926
2017	83	231	$35,722
2018	114	506	$82,953
2019	162	900	$55,301
2020	179	934	$48,375
2021	228	1,087	$52,049
2022	252	1,153	$70,293
2023	286	1,592	$104,372
2024	313	1,515	$307,595

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	34	$1,514
2016	N/R	24	$1,283
2017	N/R	28	$1,307
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	54	138	$252
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	152	190	$131
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	121	356	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	88	139	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	132	391	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	77	3,030	$53,520
Jardiance	Empagliflozin	41	1,530	$29,931
Sevelamer Carbonate	Sevelamer Carbonate	49	2,478	$9,456
Potassium Citrate Er	Potassium Citrate	16	945	$3,458
Febuxostat	Febuxostat	29	930	$2,691

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$50	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tarvinder Singh Matharu, M.D.?

Tedicare shows public-source Medicare data for Tarvinder Singh Matharu, M.D. (NPI 1912985615), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tarvinder Singh Matharu, M.D. have ACO affiliation data?

Tarvinder Singh Matharu, M.D. is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Tarvinder Singh Matharu, M.D.?

Tarvinder Singh Matharu, M.D. is linked to KIDNEY AND HYPERTENSION SPECIALISTS PLLC (billing NPI 1174649354) in the available physician profile data.

Does Tarvinder Singh Matharu, M.D. have Open Payments data?

Tarvinder Singh Matharu, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.